Differential effects of IGF-I, IGF-II and insulin in human preadipocytes and adipocytes - Role of insulin and IGF-I receptors

Molecular and Cellular Endocrinology

Volumn 339, Issue 1-2, 2011, Pages 130-135

  Bäck, Karolina ^a   Brännmark, Cecilia ^a   Strålfors, Peter ^a   Arnqvist, Hans J ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

DNA synthesis; Glucose metabolism; Growth factors; Hybrid receptors; Receptor activation

Indexed keywords

GLUCOSE; HYBRID PROTEIN; INSULIN; INSULIN RECEPTOR; SOMATOMEDIN B; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ADIPOCYTE; ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; DNA SYNTHESIS; GLUCOSE TRANSPORT; HORMONE ACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION;

ADIPOCYTES; CELLS, CULTURED; DNA REPLICATION; GLUCOSE; HUMANS; IMMUNOPRECIPITATION; INSULIN; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; PHOSPHORYLATION; PROTEIN BINDING; RECEPTOR, IGF TYPE 1; RECEPTOR, INSULIN; THYMIDINE;

EID: 79958044628     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2011.04.005     Document Type: Article

References (37)

1. Bäck K., Arnqvist H.J. Changes in insulin and IGF-I receptor expression during differentiation of human preadipocytes. Growth Horm. IGF Res. 2009, 19(2):101-111.
2. Belfiore A., Frasca F., Pandini G., Sciacca L., Vigneri R. Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease. Endocr. Rev. 2009, 30(6):586-623.
3. Blakesley V.A., Scrimgeour A., Esposito D., Le Roith D. Signaling via the insulin-like growth factor-I receptor: does it differ from insulin receptor signaling?. Cytokine Growth Factor Rev. 1996, 7(2):153-159.
4. Bolinder J., Lindblad A., Engfeldt P., Arner P. Studies of acute effects of insulin-like growth factors I and II in human fat cells. J. Clin. Endocrinol. Metab. 1987, 65(4):732-737.
5. Bornfeldt K.E., Gidlof R.A., Wasteson A., Lake M., Skottner A., Arnqvist H.J. Binding and biological effects of insulin, insulin analogues and insulin-like growth factors in rat aortic smooth muscle cells. Comparison of maximal growth promoting activities. Diabetologia 1991, 34(5):307-313.
6. Chao W., D'Amore P.A. IGF2: epigenetic regulation and role in development and disease. Cytokine Growth Factor Rev. 2008, 19(2):111-120.
7. Chisalita S.I., Nitert M.D., Arnqvist H.J. Characterisation of receptors for IGF-I and insulin; evidence for hybrid insulin/IGF-I receptor in human coronary artery endothelial cells. Growth Horm. IGF Res. 2006, 16(4):258-266.
8. Ciaraldi T.P., Carter L., Seipke G., Mudaliar S., Henry R.R. Effects of the long-acting insulin analog insulin glargine on cultured human skeletal muscle cells: comparisons to insulin and IGF-I. J. Clin. Endocrinol. Metab. 2001, 86(12):5838-5847.
9. Danielsson A., Öst A., Lystedt E., Kjolhede P., Gustavsson J., Nyström F.H., Strålfors P. Insulin resistance in human adipocytes occurs downstream of IRS1 after surgical cell isolation but at the level of phosphorylation of IRS1 in type 2 diabetes. FEBS J. 2005, 272(1):141-151.
10. Danielsson A., Nystrom F.H., Stralfors P. Phosphorylation of IRS1 at serine 307 and serine 312 in response to insulin in human adipocytes. Biochem. Biophys. Res. Commun. 2006, 342(4):1183-1187.
11. De Meyts P., Whittaker J. Structural biology of insulin and IGF1 receptors: implications for drug design. Nat. Rev. Drug Discov. 2002, 1(10):769-783.
12. Denley A., Bonython E.R., Booker G.W., Cosgrove L.J., Forbes B.E., Ward C.W., Wallace J.C. Structural determinants for high-affinity binding of insulin-like growth factor II to insulin receptor (IR)-A, the exon 11 minus isoform of the IR. Mol. Endocrinol. 2004, 18(10):2502-2512.
13. DiGirolamo M., Eden S., Enberg G., Isaksson O., Lonnroth P., Hall K., Smith U. Specific binding of human growth hormone but not insulin-like growth factors by human adipocytes. FEBS Lett. 1986, 205(1):15-19.
14. Engberding N., San Martin A., Martin-Garrido A., Koga M., Pounkova L., Lyons E., Lassegue B., Griendling K.K. Insulin-like growth factor-1 receptor expression masks the antiinflammatory and glucose uptake capacity of insulin in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 2009, 29(3):408-415.
15. Frasca F., Pandini G., Sciacca L., Pezzino V., Squatrito S., Belfiore A., Vigneri R. The role of insulin receptors and IGF-I receptors in cancer and other diseases. Arch. Physiol. Biochem. 2008, 114(1):23-37.
16. Frattali A.L., Pessin J.E. Relationship between alpha subunit ligand occupancy and beta subunit autophosphorylation in insulin/insulin-like growth factor-1 hybrid receptors. J. Biol. Chem. 1993, 268(10):7393-7400.
17. Frystyk J. Free insulin-like growth factors - measurements and relationships to growth hormone secretion and glucose homeostasis. Growth Horm. IGF Res. 2004, 14(5):337-375.
18. Halvorsen Y.D., Bond A., Sen A., Franklin D.M., Lea-Currie Y.R., Sujkowski D., Ellis P.N., Wilkison W.O., Gimble J.M. Thiazolidinediones and glucocorticoids synergistically induce differentiation of human adipose tissue stromal cells: biochemical, cellular, and molecular analysis. Metabolism 2001, 50(4):407-413.
19. Hauner H., Rohrig K., Spelleken M., Liu L.S., Eckel J. Development of insulin-responsive glucose uptake and GLUT4 expression in differentiating human adipocyte precursor cells. Int. J. Obes. Relat. Metab. Disord. 1998, 22(5):448-453.
20. Hedman C.A., Frystyk J., Lindström T., Chen J.W., Flyvbjerg A., Orskov H., Arnqvist H.J. Residual beta-cell function more than glycemic control determines abnormalities of the insulin-like growth factor system in type 1 diabetes. J. Clin. Endocrinol. Metab. 2004, 89(12):6305-6309.
21. Juul A., Dalgaard P., Blum W.F., Bang P., Hall K., Michaelsen K.F., Muller J., Skakkebaek N.E. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I. IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. J. Clin. Endocrinol. Metab. 1995, 80(8):2534-2542.
22. Karlsson M., Thorn H., Danielsson A., Stenkula K.G., Öst A., Gustavsson J., Nyström F.H., Strålfors P. Colocalization of insulin receptor and insulin receptor substrate-1 to caveolae in primary human adipocytes. Cholesterol depletion blocks insulin signalling for metabolic and mitogenic control. Eur. J. Biochem. 2004, 271(12):2471-2479.
23. Kim J.J., Accili D. Signalling through IGF-I and insulin receptors: where is the specificity?. Growth Horm. IGF Res. 2002, 12(2):84-90.
24. Lammers R., Gray A., Schlessinger J., Ullrich A. Differential signalling potential of insulin- and IGF-1-receptor cytoplasmic domains. EMBO J. 1989, 8(5):1369-1375.
25. Moxham C.P., Duronio V., Jacobs S. Insulin-like growth factor I receptor beta-subunit heterogeneity. Evidence for hybrid tetramers composed of insulin-like growth factor I and insulin receptor heterodimers. J. Biol. Chem. 1989, 264(22):13238-13244.
26. Navarro I., Leibush B., Moon T.W., Plisetskaya E.M., Banos N., Mendez E., Planas J.V., Gutierrez J. Insulin, insulin-like growth factor-I (IGF-I) and glucagon: the evolution of their receptors. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 1999, 122(2):137-153.
27. Rodbell M. Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolism and lipolysis. J. Biol. Chem. 1964, 239:375-380.
28. Saltiel A.R., Kahn C.R. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001, 414(6865):799-806.
29. Sesti G., D'Alfonso R., Vargas Punti M.D., Frittitta L., Trischitta V., Liu Y.Y., Borboni P., Longhi R., Montemurro A., Lauro R. Peptide-based radioimmunoassay for the two isoforms of the human insulin receptor. Diabetologia 1995, 38(4):445-453.
30. Siddle K., Urso B., Niesler C.A., Cope D.L., Molina L., Surinya K.H., Soos M.A. Specificity in ligand binding and intracellular signalling by insulin and insulin-like growth factor receptors. Biochem. Soc. Trans. 2001, 29(Pt. 4):513-525.
31. Sinha M.K., Buchanan C., Leggett N., Martin L., Khazanie P.G., Dimarchi R., Pories W.J., Caro J.F. Mechanism of IGF-I-stimulated glucose transport in human adipocytes. Demonstration of specific IGF-I receptors not involved in stimulation of glucose transport. Diabetes 1989, 38(10):1217-1225.
32. Sinha M.K., Buchanan C., Raineri-Maldonado C., Khazanie P., Atkinson S., DiMarchi R., Caro J.F. IGF-II receptors and IGF-II-stimulated glucose transport in human fat cells. Am. J. Physiol. 1990, 258(3 Pt 1):E534-E542.
33. Slaaby R., Schaffer L., Lautrup-Larsen I., Andersen A.S., Shaw A.C., Mathiasen I.S., Brandt J. Hybrid receptors formed by insulin receptor (IR) and insulin-like growth factor I receptor (IGF-IR) have low insulin and high IGF-1 affinity irrespective of the IR splice variant. J. Biol. Chem. 2006, 281(36):25869-25874.
34. Soos M.A., Field C.E., Siddle K. Purified hybrid insulin/insulin-like growth factor-I receptors bind insulin-like growth factor-I, but not insulin, with high affinity. Biochem. J. 1993, 290(Pt 2):419-426.
35. Ullrich A., Gray A., Tam A.W., Yang-Feng T., Tsubokawa M., Collins C., Henzel W., Le Bon T., Kathuria S., Chen E., Jacobs S., Francke U., Ramachandran J., Fujita-Yamaguchi Y. Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J. 1986, 5(10):2503-2512.
36. Ward C.W., Lawrence M.C. Ligand-induced activation of the insulin receptor: a multi-step process involving structural changes in both the ligand and the receptor. Bioessays 2009, 31(4):422-434.
37. Werner H., Weinstein D., Bentov I. Similarities and differences between insulin and IGF-I: structures, receptors, and signalling pathways. Arch. Physiol. Biochem. 2008, 114(1):17-22.